On January 5, 2015, the board of directors of Echo Therapeutics, Inc. appointed Scott W. Hollander, the company's president and chief executive officer, to fill a vacancy on the board. Mr. Hollander will serve as a Class I director of the company.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |